BioCryst To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting

By: via Benzinga
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the presentation of trial results related to intravenous (I.V.) peramivir ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.